Larvol Delta - Allyx-Therapeutics-to-Present-Phase-1-Data-for-Lead-Compound-ALX001-at-the-16th-Clinical-Trials-on-Alzheimer39s-Disease-Meeting

ALX-001 - Allyx Therap

https://www.globenewswire.com/news-release/2023/10/19/2763660/0/en/Allyx-Therapeutics-to-Present-Phase-1-Data-for-Lead-Compound-ALX-001-at-the-16th-Clinical-Trials-on-Alzheimer-s-Disease-Meeting.html

Oct 19, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next